Nuwellis Inc.

NASDAQ: NUWE · Real-Time Price · USD
5.33
-0.31 (-5.50%)
At close: Aug 15, 2025, 12:55 PM

Company Description

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy.

The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics.

Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter.

The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom.

The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021.

Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Nuwellis Inc.
Nuwellis Inc. logo
Country United States
IPO Date Feb 16, 2012
Industry Medical - Devices
Sector Healthcare
Employees 38
CEO John L. Erb

Contact Details

Address:
12988 Valley View Road
Eden Prairie, Minnesota
United States
Website https://www.nuwellis.com

Stock Details

Ticker Symbol NUWE
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001506492
CUSIP Number 67113Y702
ISIN Number US67113Y7022
Employer ID 68-0533453
SIC Code 3845

Key Executives

Name Position
John L. Erb Interim President, Interim Chief Executive Officer & Chairman of the Board
Robert B. Scott Chief Financial Officer
Betsy Riemenschneider Vice President of Sales
Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H. Chief Medical Officer & Member of Medical Advisory Board
Neil P. Ayotte Esq. Senior Vice President, General Counsel, Secretary & Chief Compliance Officer
Paul Wotta Corporate Controller
Sandra Eayrs Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Aug 14, 2025 10-Q Quarterly Report
Aug 14, 2025 8-K Current Report
Aug 04, 2025 8-K Current Report
Jul 23, 2025 8-K Current Report
Jul 14, 2025 DEF 14A Filing
Jul 03, 2025 PRE 14A Filing
Jul 02, 2025 8-K Current Report
Jul 01, 2025 4 Filing
Jun 23, 2025 8-K Current Report
Jun 16, 2025 SCHEDULE 13D Filing